Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-16 Sale | 2023-06-20 5:30 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 2,275 | $18.99 | $43,202 | 39,483 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:16 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 384 | $19.97 | $7,668 | 15,998 (Direct) | View |
| 2023-01-18 Sale | 2023-01-20 3:57 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,000 | $22.59 | $135,540 | 18,382 (Direct) | View |
| 2022-12-13 Sale | 2022-12-15 5:09 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,800 | $23.44 | $159,384 | 24,382 (Direct) | View |
| 2022-11-29 Sale | 2022-12-01 4:14 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,200 | $25.38 | $157,356 | 20,182 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 5:26 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 596 | $16.87 | $10,055 | 7,302 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 2:19 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 504 | $37.6 | $18,950 | 6,364 (Direct) | View |
| 2020-02-05 Sale | 2020-02-05 1:19 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 2,122 | $60.95 | $129,332 | 2,423 (Direct) | View |
| 2020-01-28 Sale | 2020-01-30 9:15 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 807 | $62.19 | $50,187 | 4,545 (Direct) | View |
| 2020-01-07 Sale | 2020-01-08 1:48 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 3,000 | $72.18 | $216,540 | 5,352 (Direct) | View |
| 2019-12-13 Sale | 2019-12-17 4:06 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 2,000 | $70.5 | $141,000 | 17,352 (Direct) | View |
| 2019-12-06 Sale | 2019-12-09 6:30 pm | uniQure N.V. | QURE | Soteropoulos Paula Director | 11,582 | $64.96 | $752,350 | 8,352 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-11 Option Award | 2023-09-13 9:16 pm | N/A 2033-09-10 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 6,500 | $0 | 6,500 (Direct) | View |
Ownership | 2023-09-13 8:52 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 0 | $0 | 28,792 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-20 5:30 pm | N/A 2033-06-13 | uniQure N.V. | QURE | Soteropoulos Paula Director | 25,760 | $0 | 39,483 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 5:24 pm | N/A 2033-05-17 | Rallybio Corp | RLYB | Soteropoulos Paula Director | 15,490 | $0 | 15,490 (Direct) | View |
| 2023-01-18 Exercise | 2023-01-20 3:57 pm | 2018-01-27 2027-01-27 | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,000 | $0 | 18,382 (Direct) | View |
| 2023-01-18 Exercise | 2023-01-20 3:57 pm | N/A N/A | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,000 | $5.37 | 18,382 (Direct) | View |
| 2022-12-13 Exercise | 2022-12-15 5:09 pm | 2018-01-27 2027-01-27 | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,800 | $0 | 24,382 (Direct) | View |
| 2022-12-13 Exercise | 2022-12-15 5:09 pm | N/A N/A | uniQure N.V. | QURE | Soteropoulos Paula Director | 3,000 | $5.37 | 24,382 (Direct) | View |
| 2022-11-29 Exercise | 2022-12-01 4:14 pm | N/A 2023-06-06 | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,200 | $0 | 20,182 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:31 pm | N/A 2032-06-15 | uniQure N.V. | QURE | Soteropoulos Paula Director | 26,890 | $0 | 34,192 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 8:11 pm | N/A 2032-05-24 | Rallybio Corp | RLYB | Soteropoulos Paula Director | 13,440 | $0 | 13,440 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 6:15 pm | N/A 2032-02-24 | uniQure N.V. | QURE | Soteropoulos Paula Director | 4,179 | $0 | 10,543 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:37 pm | N/A 2032-01-03 | Rallybio Corp | RLYB | Soteropoulos Paula Director | 5,369 | $0 | 5,369 (Direct) | View |
Ownership | 2021-07-29 7:39 pm | N/A N/A | Rallybio Corp | RLYB | Soteropoulos Paula Director | 0 | $0 | 37,322 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:23 pm | N/A 2031-02-25 | uniQure N.V. | QURE | Soteropoulos Paula Director | 6,489 | $0 | 10,975 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 3:49 pm | N/A 2030-02-27 | uniQure N.V. | QURE | Soteropoulos Paula Director | 5,683 | $0 | 8,106 (Direct) | View |
| 2019-12-13 Exercise | 2019-12-17 4:06 pm | N/A 2027-01-27 | uniQure N.V. | QURE | Soteropoulos Paula Director | 2,000 | $0 | 17,352 (Direct) | View |
| 2019-12-13 Exercise | 2019-12-17 4:06 pm | N/A N/A | uniQure N.V. | QURE | Soteropoulos Paula Director | 2,000 | $5.37 | 17,352 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Soteropoulos Paula Chief Executive Officer | 1,856,382 | $6.48 | 794,098 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS INC. | AKCA | Soteropoulos Paula Chief Executive Officer | 2,061,861 | $0 | 794,098 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Soteropoulos Paula Chief Executive Officer | 1,383,712 | $16.64 | 794,098 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Soteropoulos Paula Chief Executive Officer | 205,479 | $12.21 | 794,098 (Direct) | View |